Selected research
Market Outlook & Growth Opportunities
Global Endovascular AAA Stent Graft System Market Outlook and Growth Opportunities 2026
Market perspective
The global Endovascular AAA Stent Graft System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Endovascular AAA Stent Graft System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Endovascular AAA Stent Graft System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Endovascular AAA Stent Graft System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Endovascular AAA Stent Graft System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Endovascular AAA Stent Graft System market include Xinmai Medical, Lifetech Scientific, Medtronic, Beijing Huaimai Taike, Terumo, Gore, Endologix, Cordis and Cook, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Endovascular AAA Stent Graft System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Endovascular AAA Stent Graft System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Endovascular AAA Stent Graft System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endovascular AAA Stent Graft System market size, projected growth trends, production technologies, key applications, and end-use industries.
Endovascular AAA Stent Graft System Segment by Company
Xinmai Medical
Lifetech Scientific
Medtronic
Beijing Huaimai Taike
Terumo
Gore
Endologix
Cordis
Cook
Endovascular AAA Stent Graft System Segment by Type
22Fr
Type II
Endovascular AAA Stent Graft System Segment by Application
Hospital
Clinic
Others
Endovascular AAA Stent Graft System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Endovascular AAA Stent Graft System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Endovascular AAA Stent Graft System market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Endovascular AAA Stent Graft System significant trends, drivers, influence factors in global and regions.
6. To analyze Endovascular AAA Stent Graft System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endovascular AAA Stent Graft System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endovascular AAA Stent Graft System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endovascular AAA Stent Graft System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Endovascular AAA Stent Graft System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endovascular AAA Stent Graft System industry.
Chapter 3: Detailed analysis of Endovascular AAA Stent Graft System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Endovascular AAA Stent Graft System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Endovascular AAA Stent Graft System in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 22Fr
- Type II
Applications
- Hospital
- Clinic
- Others
Companies covered
- Xinmai Medical
- Lifetech Scientific
- Medtronic
- Beijing Huaimai Taike
- Terumo
- Gore
- Endologix
- Cordis
- Cook
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Endovascular AAA Stent Graft System Sales Value (2021-2032)
- 1.2.2 Global Endovascular AAA Stent Graft System Sales Volume (2021-2032)
- 1.2.3 Global Endovascular AAA Stent Graft System Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Endovascular AAA Stent Graft System Market Dynamics
- 2.1 Endovascular AAA Stent Graft System Industry Trends
- 2.2 Endovascular AAA Stent Graft System Industry Drivers
- 2.3 Endovascular AAA Stent Graft System Industry Opportunities and Challenges
- 2.4 Endovascular AAA Stent Graft System Industry Restraints
3 Endovascular AAA Stent Graft System Market by Company
- 3.1 Global Endovascular AAA Stent Graft System Company Revenue Ranking in 2025
- 3.2 Global Endovascular AAA Stent Graft System Revenue by Company (2021-2026)
- 3.3 Global Endovascular AAA Stent Graft System Sales Volume by Company (2021-2026)
- 3.4 Global Endovascular AAA Stent Graft System Average Price by Company (2021-2026)
- 3.5 Global Endovascular AAA Stent Graft System Company Ranking (2024-2026)
- 3.6 Global Endovascular AAA Stent Graft System Company Manufacturing Base and Headquarters
- 3.7 Global Endovascular AAA Stent Graft System Company Product Type and Application
- 3.8 Global Endovascular AAA Stent Graft System Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Endovascular AAA Stent Graft System Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Endovascular AAA Stent Graft System Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Endovascular AAA Stent Graft System Market by Type
- 4.1 Endovascular AAA Stent Graft System Type Introduction
- 4.1.1 22Fr
- 4.1.2
- 4.2 Global Endovascular AAA Stent Graft System Sales Volume by Type
- 4.2.1 Global Endovascular AAA Stent Graft System Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Endovascular AAA Stent Graft System Sales Volume by Type (2021-2032)
- 4.2.3 Global Endovascular AAA Stent Graft System Sales Volume Share by Type (2021-2032)
- 4.3 Global Endovascular AAA Stent Graft System Sales Value by Type
- 4.3.1 Global Endovascular AAA Stent Graft System Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Endovascular AAA Stent Graft System Sales Value by Type (2021-2032)
- 4.3.3 Global Endovascular AAA Stent Graft System Sales Value Share by Type (2021-2032)
5 Endovascular AAA Stent Graft System Market by Application
- 5.1 Endovascular AAA Stent Graft System Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Endovascular AAA Stent Graft System Sales Volume by Application
- 5.2.1 Global Endovascular AAA Stent Graft System Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Endovascular AAA Stent Graft System Sales Volume by Application (2021-2032)
- 5.2.3 Global Endovascular AAA Stent Graft System Sales Volume Share by Application (2021-2032)
- 5.3 Global Endovascular AAA Stent Graft System Sales Value by Application
- 5.3.1 Global Endovascular AAA Stent Graft System Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Endovascular AAA Stent Graft System Sales Value by Application (2021-2032)
- 5.3.3 Global Endovascular AAA Stent Graft System Sales Value Share by Application (2021-2032)
6 Endovascular AAA Stent Graft System Regional Sales and Value Analysis
- 6.1 Global Endovascular AAA Stent Graft System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Endovascular AAA Stent Graft System Sales by Region (2021-2032)
- 6.2.1 Global Endovascular AAA Stent Graft System Sales by Region: 2021-2026
- 6.2.2 Global Endovascular AAA Stent Graft System Sales by Region (2027-2032)
- 6.3 Global Endovascular AAA Stent Graft System Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Endovascular AAA Stent Graft System Sales Value by Region (2021-2032)
- 6.4.1 Global Endovascular AAA Stent Graft System Sales Value by Region: 2021-2026
- 6.4.2 Global Endovascular AAA Stent Graft System Sales Value by Region (2027-2032)
- 6.5 Global Endovascular AAA Stent Graft System Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Endovascular AAA Stent Graft System Sales Value (2021-2032)
- 6.6.2 North America Endovascular AAA Stent Graft System Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Endovascular AAA Stent Graft System Sales Value (2021-2032)
- 6.7.2 Europe Endovascular AAA Stent Graft System Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Endovascular AAA Stent Graft System Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Endovascular AAA Stent Graft System Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Endovascular AAA Stent Graft System Sales Value (2021-2032)
- 6.9.2 South America Endovascular AAA Stent Graft System Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Endovascular AAA Stent Graft System Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Endovascular AAA Stent Graft System Sales Value Share by Country, 2025 VS 2032
7 Endovascular AAA Stent Graft System Country-level Sales and Value Analysis
- 7.1 Global Endovascular AAA Stent Graft System Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Endovascular AAA Stent Graft System Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Endovascular AAA Stent Graft System Sales by Country (2021-2032)
- 7.3.1 Global Endovascular AAA Stent Graft System Sales by Country (2021-2026)
- 7.3.2 Global Endovascular AAA Stent Graft System Sales by Country (2027-2032)
- 7.4 Global Endovascular AAA Stent Graft System Sales Value by Country (2021-2032)
- 7.4.1 Global Endovascular AAA Stent Graft System Sales Value by Country (2021-2026)
- 7.4.2 Global Endovascular AAA Stent Graft System Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.9.2 France Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.16.2 China Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.19.2 India Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Endovascular AAA Stent Graft System Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Endovascular AAA Stent Graft System Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Endovascular AAA Stent Graft System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Xinmai Medical
- 8.1.1 Xinmai Medical Company Information
- 8.1.2 Xinmai Medical Business Overview
- 8.1.3 Xinmai Medical Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Xinmai Medical Endovascular AAA Stent Graft System Product Portfolio
- 8.1.5 Xinmai Medical Recent Developments
- 8.2 Lifetech Scientific
- 8.2.1 Lifetech Scientific Company Information
- 8.2.2 Lifetech Scientific Business Overview
- 8.2.3 Lifetech Scientific Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Lifetech Scientific Endovascular AAA Stent Graft System Product Portfolio
- 8.2.5 Lifetech Scientific Recent Developments
- 8.3 Medtronic
- 8.3.1 Medtronic Company Information
- 8.3.2 Medtronic Business Overview
- 8.3.3 Medtronic Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Medtronic Endovascular AAA Stent Graft System Product Portfolio
- 8.3.5 Medtronic Recent Developments
- 8.4 Beijing Huaimai Taike
- 8.4.1 Beijing Huaimai Taike Company Information
- 8.4.2 Beijing Huaimai Taike Business Overview
- 8.4.3 Beijing Huaimai Taike Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Beijing Huaimai Taike Endovascular AAA Stent Graft System Product Portfolio
- 8.4.5 Beijing Huaimai Taike Recent Developments
- 8.5 Terumo
- 8.5.1 Terumo Company Information
- 8.5.2 Terumo Business Overview
- 8.5.3 Terumo Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Terumo Endovascular AAA Stent Graft System Product Portfolio
- 8.5.5 Terumo Recent Developments
- 8.6 Gore
- 8.6.1 Gore Company Information
- 8.6.2 Gore Business Overview
- 8.6.3 Gore Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Gore Endovascular AAA Stent Graft System Product Portfolio
- 8.6.5 Gore Recent Developments
- 8.7 Endologix
- 8.7.1 Endologix Company Information
- 8.7.2 Endologix Business Overview
- 8.7.3 Endologix Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Endologix Endovascular AAA Stent Graft System Product Portfolio
- 8.7.5 Endologix Recent Developments
- 8.8 Cordis
- 8.8.1 Cordis Company Information
- 8.8.2 Cordis Business Overview
- 8.8.3 Cordis Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Cordis Endovascular AAA Stent Graft System Product Portfolio
- 8.8.5 Cordis Recent Developments
- 8.9 Cook
- 8.9.1 Cook Company Information
- 8.9.2 Cook Business Overview
- 8.9.3 Cook Endovascular AAA Stent Graft System Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Cook Endovascular AAA Stent Graft System Product Portfolio
- 8.9.5 Cook Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Endovascular AAA Stent Graft System Value Chain Analysis
- 9.1.1 Endovascular AAA Stent Graft System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Endovascular AAA Stent Graft System Sales Mode & Process
- 9.2 Endovascular AAA Stent Graft System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Endovascular AAA Stent Graft System Distributors
- 9.2.3 Endovascular AAA Stent Graft System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst